15 Spinal Muscular Atrophy Clinical Trials in Commack, NY (2026)

Q: How do I join a clinical trial in Commack?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Commack research site will contact you.

Recruiting Spinal Muscular Atrophy Studies in Commack

NCT05967689Recruiting

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

The purpose of this study is to evaluate the safety, efficacy and pharmacokinetics (PK) of zipalertinib in participants with locally advanced or metastatic Non-Small Cell Lung Cancer (NSCLC) harboring...

Commack, NYPHASE2220 participantsTaiho Oncology, Inc.

View Study Details

NCT06033248Recruiting

Using Urine Samples to Identify Lung Cancer

The researchers are doing this study to test the ability of an animal biosensor platform (ABP) to detect NSCLC. Participants in this study will either be diagnosed with NSCLC, suspected to have NSCLC,...

Commack, NY210 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05424029Recruiting

Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer

The purpose of this study is to find out if fluid rinsed from peoples' airways (bronchial washing samples) during routine surgery to remove (resect) their non-small cell lung cancer (NSCLC) tumors con...

Commack, NY200 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07690917Recruiting

A Study of a New PET Scanner in People With Cancer

The researchers are doing this study to test the capabilities of a new total-body PET scanner called the Biograph Vision Quadra. The researchers want to learn whether this scanner can produce better P...

Commack, NY90 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT01639508Recruiting

Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity

The purpose of this phase II study is to find out what effects cabozantinib (XL184) has, good and/or bad, in patients whose tumors one of the following gene changes RET, ROS1, or NTRK fusion, or incre...

Commack, NYPHASE286 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06957314Recruiting

A Study of Hospital-at-Home for People Receiving Tarlatamab

The purpose of this study is to find out whether a Hospital-at-Home (HaH) program is a more efficient way to monitor people's health after receiving tarlatamab than monitoring in the hospital (inpatie...

Commack, NYNA70 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05657873Recruiting

A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)

The purpose of this study is to see whether adding liver stereotactic ablative radiotherapy/L-SABR to standard drug therapy is better than standard drug therapy alone for people with metastatic non-sm...

Commack, NYPHASE268 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07535437Recruiting

A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer

The researchers are doing this study to find out whether ivonescimab in combination with datopotamab deruxtecan- (Dato-DXd) or osimertinib are safe and effective treatments in people with non-small ce...

Commack, NYPHASE166 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07218601Recruiting

Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer

The researchers are doing this study to test the ability of a new technology called breathprinting, or electronic nose (E-Nose), to measure changes in certain chemicals in the breath before and after ...

Commack, NYPHASE260 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07535463Recruiting

A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer

The researchers are doing this study to test the safety of ivonescimab given in combination with standard chemotherapy and stereotactic radiosurgery (SRS) in people with non-small cell lung cancer (NS...

Commack, NYPHASE153 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06582771Recruiting

A Study of Sotorasib in People with Non-Small Cell Lung Cancer

The researchers are doing this study to see if sotorasib is a safe and effective treatment for people with advanced non-small cell lung cancer (NSCLC) with a KRAS G12C mutation who have not received t...

Commack, NYPHASE239 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07594522Recruiting

A Study of Ivonescimab in People With Non-Small Cell Lung Cancer

The researchers are doing this study to find out whether ivonescimab after receiving standard stereotactic body radiotherapy (SBRT) is an effective treatment in people with Non-Small Cell Lung Cancer ...

Commack, NYPHASE136 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06807632Recruiting

A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer

This study will test whether valemetostat in combination with atezolizumab is a safe treatment that causes few or mild side effects in people with extensive-stage small cell lung cancer (SCLC). The re...

Commack, NYPHASE124 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07619339Recruiting

A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer

The researchers are doing this study to find out whether the combination of tepotinib and ivonescimab is a safe and effective treatment for people with non-small cell lung cancer (NSCLC) that is posit...

Commack, NYPHASE116 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07428044Recruiting

A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer

The purpose of this study is to find out how many people with HER2-amplified or HER2-mutated non-small cell lung cancer (NSCLC) experience a decrease in tumor viability when they receive trastuzumab d...

Commack, NYPHASE214 participantsMemorial Sloan Kettering Cancer Center

View Study Details

About Spinal Muscular Atrophy Clinical Trials in Commack

Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder that causes loss of motor neurons, leading to progressive muscle weakness and atrophy. It is the leading genetic cause of infant death. Revolutionary gene therapies and SMN-enhancing drugs have transformed treatment.

There are currently 15 spinal muscular atrophy clinical trials recruiting participants in Commack, NY. These studies are seeking a combined 1,252 participants. Research is being sponsored by Taiho Oncology, Inc., Memorial Sloan Kettering Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.

Spinal Muscular Atrophy Clinical Trials in Commack — FAQ

Are there spinal muscular atrophy clinical trials in Commack?

Yes, there are 15 spinal muscular atrophy clinical trials currently recruiting in Commack, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Commack?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Commack research site will contact you about next steps.

Are clinical trials in Commack free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Commack studies also compensate for your time and travel.

What spinal muscular atrophy treatments are being tested?

The 15 active trials in Commack are testing new therapies including novel drugs, biologics, and treatment approaches for spinal muscular atrophy.

Data updated July 21, 2026 from ClinicalTrials.gov